Nearly 4% of the world’s population is affected by one or more of 80 autoimmune diseases identified to date. By 2025, the autoimmune disease treatment market is estimated to reach a staggering $7.95B in value.
This guide takes a closer look at five of the most common autoimmune diseases: rheumatoid arthritis, lupus, type 1 diabetes, atherosclerosis, and inflammatory bowel disease. It also dives into current and novel therapeutic approaches and identifies the different inflammatory pathways as potential therapeutic targets for the treatments and diagnostics for cancer & autoimmune diseases.
"*" indicates required fields